Drug Pipeline

Valsartan Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
5
Recruiting
2
Phase 3
8
Top Sponsors
Active Studies by Phase
Phase 4
2
Phase 2/3
2
Phase 2
1
Phase 1/2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06536309 Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved… Heart Failure With Preserved Ejection Fraction Not Yet Recruiting
NCT07547878 Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Chronic Kidney Disease Not Yet Recruiting
Phase 2/3
NCT04971720 PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis Obesity Recruiting
NCT07539298 Effects of VALsartan On atRIAl Mitral Regurgitation Atrial Functional Mitral Regurgitation Not Yet Recruiting
Phase 2
NCT06053580 Repurposing Valsartan May Protect Against Pulmonary Hypertension Pulmonary Arterial Hypertension Recruiting
Phase 1/2
NCT05194111 Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan Heart Failure Recruiting
Phase 1
NCT07331389 A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam… Overweight Subject Recruiting
Not specified
NCT07491718 Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy Takotsubo Cardiomyopathy Recruiting
Sponsors Running Valsartan Trials
University of Alabama at Birmingham (1) Virginia Commonwealth University (1) University of Washington (1) Brigham and Women's Hospital (1) Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (1) University of Edinburgh (1) Jonathan Beaudoin (1) Baylor Research Institute (1)
Disease Areas
Heart Failure (3) Hypertension (2) Obesity (2) Heart Disease (1) Type 2 Diabetes (1) Diabetes (1) Chronic Kidney Disease (1)
Get alerts when Valsartan trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free